NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
EPIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPIC
ST13
US500000097642362Class
1, 5, 40, 42, 44
Filing
97642362
Registration
7629331
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
12/31/2024
Trademark type
Word
Nice classes
1, 5, 40, 42, 44
Filing date
10/21/2022
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Wien, AT
Examiner
CLYBURN, CARLA DIONNE
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
invIOs GmbH
Representatives
Michael J. Leonard FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Human immune cellsin particular T cellsfor scientific and medical research
Class 5
Chemicalbiological and biochemical preparations and reagents for the cultivation of human immune cellsin particular T cellsfor medical purposes in the treatment of immuno-oncological diseases; Human immune cellsin particular T cellsfor medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cellsin particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapyin particular immune cell therapyin particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cellsin particular T-cellsfor the treatment of inflammatory diseasesdiseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cellsin particular T-cellsfor the treatment of inflammatory diseasesdiseases of the immune system and cancer; biological preparations and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases
Class 40
Contract manufacturing of therapeutic medicinal productsContract manufacturing of cell therapies for the treatment of inflammatory diseasesdiseases of the immune system and cancer; Contract manufacturing for othersin particular manufacturing of pharmaceutical preparations for health carefor the treatment of people suffering from diseases treated by cell therapy or regenerative medicine productsmedicinal products for human use including investigational medicinal productsinvestigational biological productscell therapy preparations and advanced therapy medicinal productsall of the foregoing not in connection with medical diagnosticscancer diagnostics and cancer profiling
Class 42
Development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnosticscancer diagnostics and cancer profiling
Class 44
Medical services related to the treatment and preparation of human cells; medical servicesimmune cell therapy; medical servicesimmune cell modification; medical servicesadministration of immune cells; medical consulting related to immune cell therapyall of the foregoing not in connection with medical diagnosticscancer diagnostics and cancer profiling
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/09/2024
RG1B
REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED
12/09/2024
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
12/09/2024
ABN6
ABANDONMENT - NO USE STATEMENT FILED
12/09/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/07/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/07/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/15/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/29/2023
GNSL
LETTER OF SUSPENSION E-MAILED
11/29/2023
CNSL
SUSPENSION LETTER WRITTEN
11/29/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/29/2023
OTHE
CASE RETURNED TO EXAMINATION
11/08/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/08/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2023
PUBO
PUBLISHED FOR OPPOSITION
08/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/19/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/30/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/23/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/18/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/18/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/18/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/10/2023
GNRT
NON-FINAL ACTION E-MAILED
04/10/2023
CNRT
NON-FINAL ACTION WRITTEN
04/10/2023
DOCK
ASSIGNED TO EXAMINER
03/31/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/06/2023
ALIE
ASSIGNED TO LIE
01/05/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2022
NWAP
NEW APPLICATION ENTERED
10/25/2022
Continuous trademark protection
Get notified about every new filing that threatens EPIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.